7 insiders reported 67 Form 4 transactions for Beam Therapeutics Inc. (BEAM) over the past 18 months (most recent 2026-07-02). Recent activity: Simon Amy (Chief Medical Officer) Sell 373 shares, Evans John M. (CEO) Buy 18,663 shares, Evans John M. (CEO) Buy 6,337 shares, Evans John M. (CEO) Sell 13,421 shares, Evans John M. (CEO) Sell 11,579 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Simon Amy | Chief Medical Officer | Sell | 373 | $12,954 |
| 2026-07-01 | Evans John M. | CEO | Buy | 18,663 | $12,504 |
| 2026-07-01 | Evans John M. | CEO | Buy | 6,337 | $6,527 |
| 2026-07-01 | Evans John M. | CEO | Sell | 13,421 | $471,528 |
| 2026-07-01 | Evans John M. | CEO | Sell | 11,579 | $415,824 |
| 2026-07-01 | Evans John M. | CEO | Buy | 25,000 | $25,750 |
| 2026-07-01 | Evans John M. | CEO | Sell | 23,100 | $791,482 |
| 2026-07-01 | Evans John M. | CEO | Sell | 1,900 | $66,203 |
| 2026-06-22 | Ciaramella Giuseppe | President | Buy | 6,505 | $4,358 |
| 2026-06-22 | Ciaramella Giuseppe | President | Buy | 29,000 | $29,870 |
| 2026-04-06 | Bellon Christine | Chief Legal Officer | Sell | 5,956 | $146,398 |
| 2026-04-06 | Ciaramella Giuseppe | President | Sell | 11,810 | $290,290 |
| 2026-04-06 | Evans John M. | CEO | Sell | 30,078 | $739,317 |
| 2026-04-06 | Simon Amy | Chief Medical Officer | Sell | 6,700 | $164,686 |
| 2026-04-06 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,242 | $79,688 |
| 2026-04-02 | Ciaramella Giuseppe | President | Buy | 40,000 | $0 |
| 2026-04-02 | Emany Sravan Kumar | Chief Financial Officer | Buy | 31,750 | $0 |
| 2026-04-02 | Bellon Christine | Chief Legal Officer | Buy | 20,000 | $0 |
| 2026-04-02 | Simon Amy | Chief Medical Officer | Buy | 31,750 | $0 |
| 2026-04-02 | Cavanagh Bethany J | SVP, Finance and Treasurer | Buy | 20,000 | $0 |
| 2026-02-26 | Ciaramella Giuseppe | President | Buy | 35,000 | $595,000 |
| 2026-02-26 | Ciaramella Giuseppe | President | Sell | 35,000 | $1.1M |
| 2026-02-02 | Evans John M. | CEO | Buy | 19,336 | $12,955 |
| 2026-02-02 | Evans John M. | CEO | Buy | 5,664 | $3,795 |
| 2026-02-02 | Evans John M. | CEO | Sell | 16,333 | $476,760 |
Source: SEC Form 4 filings · as of 2026-07-02